February 22, 2010 – The session “The Future is Now: Changing Paradigms in Atrial Fibrillation (AF) Management,” will take place 8 a.m. to noon Saturday, March 13 in Atlanta, Ga., in room A301, Georgia World Congress Center.
February 22, 2010 – RIS/PACS maker Merge Healthcare Inc. said today it is making a bid to purchased the PACS company AMICAS. However, Amicas says it already entered into a merger deal with another company.
February 19, 2010 – The use of medical technology in the United States increased dramatically between 1996 and 2006, according to “Health, United States, 2009,” the federal government’s 33rd annual report to the president and Congress on the health of all Americans.
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
February 19, 2010 – For women concerned about heart disease, routine testing of high-sensitivity C-reactive protein (hs-CRP) is controversial, said Thomas Behrenbeck, M.D., Ph.D., a Mayo Clinic cardiologist, in an interview in the February issue of Mayo Clinic Women’s HealthSource.
February 19, 2010 – A chemical compound found normally in the blood has shown promise in treating and preventing an intractable form of heart failure in a mouse model of the disease, report researchers at the University of Illinois at Chicago College of Medicine. The study is published in the February issue of Circulation.
February 18, 2010 - Clinicians treating the citizens of Concepcion, Honduras and surrounding rural area will now have access to specialists in the United States, thanks to Medweb’s recent PACS donation to Shoulder to Shoulder Inc., a nonprofit organization dedicated to creating an integrated healthcare system in Honduras.
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
February 17, 2010 — An agreement has been reached to further augment and diversify a manufacturer's supply of molybdenum 99 (Mo 99) to produce the medical isotope technetium 99m (Tc 99m).
February 16, 2010 — The first in a series of free Virtual Healthcare IT Conferences kicks off next week.
Feb 16, 2010 — East Orange General Hospital, in East Orange, N.J., purchased a new hospital-based electronic medical record (EMR) offering in an effort to reduce cost and enhance patient care.
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
February 15, 2010 – A small pocket-sized ultrasound system was released today to provide physicians with imaging capabilities at the point-of-care. GE Healthcare today announced the availability of its Vscan, which is roughly the size of a smart phone. It received FDA 510(k) clearance, CE mark in the European Union, and a medical device license from Health Canada.
February 12, 2010 – With the U.S. population growing older and cardiology patient volume expected to increase in the coming years, cardiology departments are being forced to do more work with the same staffing levels.
February 12, 2010 - After the U.S. FDA announced it is launching a program designed to reduce unnecessary medical radiation exposure with a focus on computed tomography, nuclear medicine and fluoroscopy, the Medical Imaging & Technology Alliance (MITA) gave its prescription for lowering radiation.
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
February 11, 2010 – Former president Bill Clinton received two coronary stents today after being admitted to the hospital with chest pain.
February 11, 2010 — An appeals court in Germany found the CoreValve transcatheter aortic valve system does not infringe Edwards Lifesciences’ German Andersen patent used in its SAPIEN aortic valve. The appellate court’s decision upholds a lower court’s ruling and enables uninterrupted access to the transcatheter heart valve in Germany.
February 11, 2010 – Changing direction from a standalone device technology, Cambridge Heart Inc. has developed an OEM module to incorporate its microvolt T-wave alternans technology into other vendor’s ECG stress test equipment. The development phase of a microvolt T-wave alternans (MTWA) OEM module has been completed and an FDA 510(k) application for regulatory approval has been filed.